CDKN2A and melanoma: Finally, two lncRNAs regulated by the BRAF pathway-MIR31HG and RMEL3- promoted melanoma proliferation and in vivo tumor growth in preclinical models by preventing p16INK4A-dependent cellular senescence and stimulating MAPK and PI3K pathways, respectively [69,70,71].